Objects
Diouf, Ibrahima, Malpas, Charles B., Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, Roos, Izanne, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Horakova, Dana, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Havrdova, Eva Kubala, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Patti, Francesco, Sinnige, LGF, Sanchez-Menoyo, JL, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Trivino, T, Gray, O, Shaygannejad, Vahid, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Ozakbas, Serkan, Moore, F, Kalincik, T, Izquierdo, Guillermo. Wiley-Blackwell; 2023. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Daruwalla, Cyrus, Shaygannejad, Vahid, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J., Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, Skibina, Olga, Ozakbas, Serkan, Buzzard, Katherine, Grammond, P, Karabudak, R, van der Walt, A, Butzkueven, H, Maimone, D, Lechner-Scott, Jeannette, Soysal, A, John, N, Prevost, J, Havrdova, Eva Kubala, Spitaleri, D, Ramo-Tello, C, Gerlach, O, Iuliano, G, Foschi, M, Ampapa, R, van Pesch, V, Barnett, M, Shalaby, N, D'hooghe, M, Horakova, Dana, Kuhle, J, Sa, MJ, Fabis-Pedrini, M, Kermode, A, Mrabet, S, Gouider, R, Hodgkinson, S, Laureys, G, Van Hijfte, L, Macdonell, R, Alroughani, Raed, Oreja-Guevara, C, Cristiano, E, McCombe, P, Sanchez-Menoyo, JL, Singhal, B, Blanco, Y, Hughes, S, Garber, J, Solaro, C, McGuigan, C, Boz, Cavit, Taylor, B, de Gans, K, Habek, M, Al-Asmi, A, Mihaela, S, Castillo Triviño, T, Al-Harbi, T, Rojas, JI, Gray, O, Khurana, D, Patti, Francesco, Van Wijmeersch, B, Grigoriadis, N, Inshasi, J, Oh, J, Aguera-Morales, E, Fragoso, Y, Moore, F, Shaw, C, Baghbanian, SM, Shuey, N, Onofrj, Marco, Willekens, B, Hardy, TA, Decoo, D, Sempere, AP, Field, D, Wynford-Thomas, R, Cunniffe, NG, Roos, I, Malpas, CB, Coles, AJ, Lugaresi, Alessandra, Kalincik, T, Brown, JWL. Sage; 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Spelman, Tim, Ozakbas, Serkan, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Morgado, Yolanda Blanco, Spitaleri, Daniele L. A., Pesch, Vincent Van, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Alroughani, Raed, Al-Asmi, Abdullah, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H, MSBase Study Group,, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Der Walt, Anneke Van, Yamout, Bassem, Lechner-Scott, Jeannette. Future Medicine; 2023. A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry.
Roos, Izanne, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Sharmin, Sifat, Ferraro, Diana, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamou, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Horakova, Dana, Maimone, D, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, MJ, Solaro, C, Havrdova, Eva Kubala, Ramo-Tello, C, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, Patti, Francesco, van der Walt, A, Butzkueven, H, Prevost, J, Sanchez-Menoyo, JL, Laureys, G, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaygannejad, Vahid, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Moore, F, Malpas, C, Ozakbas, Serkan, Kalincik, T, Izquierdo, Guillermo, Eichau, Sara. Sage Publications Ltd.; 2023. Comparative effectiveness in multiple sclerosis: A methodological comparison.
Andersen, Johanna B., Sharmin, Sifat, Lefort, Mathilde, Koch-Henriksen, Nils, Sellebjerg, Finn, Sørensen, Per Soelberg, Hilt Christensen, Claudia C., Rasmussen, Peter V., Jensen, Michael B., Frederiksen, Jette L., Bramow, Stephan, Mathiesen, Henrik K., Schreiber, Karen I., Horakova, Dana, Havrdova, Eva K., Alroughani, Read, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Patti, Francesco, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, Jenette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Skibina, O, Solaro, C, Karabudak, R, Wijmeersch, BV, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, Sèze, JD, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, JP, Marousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Leray, E, Laplaud, DA, Butzkueven, H, Kalincik, T, Vukusic, S, Magyari, M. Elsevier; 2021. The effectiveness of natalizumab vs fingolimod - A comparison of international registry studies.
Kalincik, Tomas, Kister, Ilya, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Bacon, Tamar E., Terzi, Murat, Boz, C, Grand'Maison, F, Bergamaschi, R, Gerlach, O, Sa, MJ, Kappos, L, Cartechini, E, Lechner-Scott, Jeannette, van Pesch, V, Malpas, Charles B., Shaygannejad, V, Granella, F, Spitaleri, D, Iuliano, G, Maimone, D, Prevost, J, Soysal, A, Turkoglu, R, Ampapa, R, Butzkueven, H, Sharmin, Sifat, Cutter, G, for MSBase Study Group,, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara. Sage; 2022. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Vitkova, Marianna, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Larochelle, Catherine, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Malpas, Charles, Sola, Patrizia, Ferraro, D, Grammond, P, Butzkueven, H, Buzzard, K, Skibina, O, Yamout, BI, Karabudak, R, Gerlach, O, Lechner-Scott, Jeannette, Horakova, Dana, Maimone, D, Bergamaschi, R, Van Pesch, V, Iuliano, G, Cartechini, E, José Sà, M, Ampapa, R, Barnett, M, Hughes, SE, Ramo-Tello, CM, Kubala Havrdova, Eva, Hodgkinson, S, Spitaleri, DLA, Petersen, T, Butler, EG, Slee, M, McGuigan, C, McCombe, PA, Granella, F, Cristiano, E, Prevost, J, Patti, Francesco, Taylor, BV, Sãnchez-Menoyo, JL, Laureys, G, Van Hijfte, L, Vucic, S, Macdonell, RA, Gray, O, Olascoaga, J, Deri, N, Fragoso, YD, Ozakbas, Serkan, Shaw, C, Kalincik, T, MSBase Study Group,, Izquierdo, Guillermo, Eichau, Sara, Shaygannejad, Vahid. Wolters Kluwer Health; 2022. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
Brochet, Bruno, Hupperts, Raymond, Langdon, Dawn, Solari, Alessandra, Piehl, Fredrik, Lechner-Scott, Jeannette, Montalban, Xavier, Selmaj, Krzysztof, Valis, Martin, Rejdak, Konrad, Havrdova, Eva K., Patti, Francesco, Alexandri, Nektaria, Nolting, Axel, Keller, Birgit. Elsevier; 2022. Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis.
Roos, Izanne, Leray, Emmanuelle, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Frascoli, Federico, Sá, Maria José, Cartechini, E, Boz, C, Granella, F, Hupperts, R, Terzi, M, Lechner-Scott, Jeannette, Spitaleri, D, Van Pesch, V, Soysal, A, Casey, Romain, Olascoaga, J, Prevost, J, Aguera-Morales, E, Slee, M, Csepany, T, Turkoglu, R, Sidhom, Y, Gouider, R, Van Wijmeersch, B, McCombe, P, Brown, J. William L., Macdonell, R, Coles, A, Malpas, CB, Butzkueven, H, Vukusic, S, Kalincik, T, , , Horakova, Dana, Havrdova, Eva K., Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo. Oxford University Press; 2020. Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Roos, Izanne, Leray, Emmanuelle, Izquierdo, Guillermo, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marco, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ciron, Jonathon, Frascoli, Federico, Ruet, A, Ozakbas, S, De Seze, J, Louapre, C, Zephir, H, Sá, MJ, Sola, P, Ferraro, D, Labauge, P, Defer, G, Casey, Romain, Bergamaschi, R, Lebrun-Frenay, C, Boz, C, Cartechini, E, Moreau, T, Laplaud, D, Lechner-Scott, Jeanette, Grand’Maison, F, Gerlach, O, Terzi, M, Brown, J. William L., Granella, F, Alroughani, R, Iuliano, G, Van Pesch, V, Van Wijmeersch, B, Spitaleri, DLA, Soysal, A, Berger, E, Prevost, J, Aguera-Morales, E, Horakova, Dana, McCombe, P, Castillo Triviño, T, Clavelou, P, Pelletier, J, Turkoglu, R, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Sidhom, Y, Havrdova, Eva Kubala, Gouider, R, Csepany, T, Bourre, B, Al Khedr, A, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanche, JP, Maurousset, A, Debouverie, Marc, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Coles, A, Malpas, CB, Vukusic, S, Butzkueven, H, Trojano, Maria, Kalincik, T, Patti, Francesco. Sage Publications; 2021. Determinants of therapeutic lag in multiple sclerosis.
Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco. BMJ Group; 2023. Disability accrual in primary and secondary progressive multiple sclerosis.
Spelman, Tim, Ozakbas, Serkan, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Blanco Morgado, Yolanda, Spitaleri, Daniele L. A., van Pesch, Vincent, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Alroughani, Raed, Al-Asmi, A, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Van Der Walt, Anneke, Yamout, Bassem, Lechner-Scott, Jeannette. Sage Publications; 2023. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Sharmin, Sifat, Lefort, Mathilde, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand'Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Andersen, Johanna Balslev, Trojano, Maria, McCombe, P, Slee, M, Lechner-Scott, Jeannette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Leray, Emmanuelle, Skibina, O, Buzzard, K, Van der Walt, A, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Horakova, Dana, Ciron, J, Ruet, A, De Seze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Havrdova, Eva Kubala, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Alroughani, Raed, Montcuquet, A, Wahab, A, Camdessanche, J-P, Maurousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Izquierdo, Guillermo, Laplaud, D, Koch-Henriksen, N, Sellebjerg, FT, Soerensen, PS, Pfleger, CC, Rasmussen, PV, Jensen, MB, Frederiksen, JL, Bramow, S, Mathiesen, HK, Ozakbas, Serkan, Schreiber, KI, Magyari, M, Vukusic, S, Butzkueven, H, Kalincik, T, Patti, Francesco. Adis International; 2021. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit. Elsevier; 2020. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder.
Spelman, Tim, Horakova, Dana, Csepany, Tunde, Boz, Cavit, Lechner-Scott, Jeannette, Granella, Franco, Grand'Maison, Francois, van der Walt, Anneke, Zhu, Chao, Butzkueven, Helmut, Ozakbas, Serkan, Alroughani, Raed, Onofrj, Marco, Kalincik, Tomas, Prat, Alexandre, Terzi, Murat, Grammond, Pierre, Patti, Francesco. Elsevier; 2023. Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity.
Kister, Ilya, Spelman, Tim, Grand'Maison, Francois, Alroughani, Raed, Terzi, Murat, Boz, Cavit, Hupperts, Raymond, Lechner-Scott, Jeannette, Kappos, Ludwig, Pucci, Eugenio, Hodgkinson, Suzanne, Solaro, Claudio, Patti, Francesco, Butzkueven, Helmut, Duquette, Pierre, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana. Elsevier; 2018. Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.
Roos, Izanne, Malpas, Charles, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marc, Ozakbas, Serkan, Grammond, Pierrre, Zephir, Helene, Ciron, Jonathan, Maillart, Elisabeth, Moreau, Thibault, Leray, Emmanuelle, Amato, MP, Labauge, P, Alroughani, R, Buzzard, K, Skibina, O, Terzi, M, Laplaud, DA, Berger, E, Grand'Maison, F, Lebrun-Frenay, C, Casey, Romain, Cartechini, E, Boz, C, Lechner-Scott, Jeanette, Clavelou, P, Stankoff, B, Prevost, J, Kappos, L, Pelletier, J, Shaygannejad, V, Yamout, B, Horakova, Dana, Khoury, SJ, Gerlach, O, Spitaleri, DLA, Van Pesch, V, Gout, O, Turkoglu, R, Heinzlef, O, Thouvenot, E, McCombe, PA, Soysal, A, Havrdova, Eva Kubala, Bourre, B, Slee, M, Castillo-Trivino, T, Bakchine, S, Ampapa, R, Butler, EG, Wahab, A, Macdonell, RA, Aguera-Morales, E, Cabre, P, Debouverie, Marc, Ben, NH, Van der Walt, A, Laureys, G, Van Hijfte, L, Ramo-Tello, CM, Maubeuge, N, Hodgkinson, S, Sanchez-Menoyo, JL, Barnett, MH, Labeyrie, C, Patti, Francesco, Vucic, S, Sidhom, Y, Gouider, R, Csepany, T, Sotoca, J, de Gans, K, Al-Asmi, A, Fragoso, YD, Vukusic, S, Butzkueven, H, De Seze, Jerome, Kalincik, T, Izquierdo, Guillermo. Wolters Kluwer Health; 2022. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Zhu, Chao, Kalincik, Tomas, Patti, Francesco, Grand'Maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Macdonell, Richard A. L., Horakova, Dana, Weinstock-Guttman, B, Ozakbas, S, Slee, M, Sa, MJ, Van Pesch, V, Barnett, M, Van Wijmeersch, B, Gerlach, O, Prevost, J, Terzi, M, Zhou, Zhen, Boz, C, Laureys, G, Van Hijfte, L, Kermode, AG, Garber, J, Yamout, B, Khoury, SJ, Merlo, D, Monif, M, Jokubaitis, V, Buzzard, Katherine, van der Walt, A, Butzkueven, H, MSBase, SG, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Kuhle, Jens. American Medical Association (AMA); 2023. Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Malpas, Charles B., Roos, Izanne, Havrdova, Eva Kubala, Izquierdo, Guillermo, Eichau, Sara, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Kalincik, Tomas, MSBase Study Group,, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Butzkueven, Helmut, Kappos, Ludwig, Patti, Francesco, Alroughani, Raed, Horakova, Dana. Springer; 2022. Multiple Sclerosis Relapses Following Cessation of Fingolimod.
Zhu, Chao, Zhou, Zhen, Alroughani, Raed, Lechner-Scott, Jeannette, Barnett, Michael, Izquierdo, Guillermo, Prat, Alexandre, Horakova, Dana, Havrdova, Eva Kubala, Macdonell, Richard, Patti, Francesco, Khoury, Samia Joseph, Roos, Izanne, Slee, M, Karabudak, R, Onofrj, M, Van Pesch, V, Prevost, J, Monif, M, Jokubaitis, V, van der Walt, A, Butzkueven, H, Merlo, Daniel, Kalincik, Tomas, Ozakbas, Serkan, Skibina, Olga, Kuhle, Jens, Hodgkinson, Suzanne, Boz, Cavit. BMJ Group; 2022. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.